BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7853573)

  • 1. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma.
    Walther MM; Choyke PL; Weiss G; Manolatos C; Long J; Reiter R; Alexander RB; Linehan WM
    J Urol; 1995 Mar; 153(3 Pt 2):913-6. PubMed ID: 7853573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.
    Herring JC; Enquist EG; Chernoff A; Linehan WM; Choyke PL; Walther MM
    J Urol; 2001 Mar; 165(3):777-81. PubMed ID: 11176466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
    Walther MM; Choyke PL; Glenn G; Lyne JC; Rayford W; Venzon D; Linehan WM
    J Urol; 1999 May; 161(5):1475-9. PubMed ID: 10210376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
    Duffey BG; Choyke PL; Glenn G; Grubb RL; Venzon D; Linehan WM; Walther MM
    J Urol; 2004 Jul; 172(1):63-5. PubMed ID: 15201738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience.
    Roupret M; Hopirtean V; Mejean A; Thiounn N; Dufour B; Chretien Y; Chauveau D; Richard S
    J Urol; 2003 Nov; 170(5):1752-5. PubMed ID: 14532769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience.
    Choyke PL; Pavlovich CP; Daryanani KD; Hewitt SM; Linehan WM; Walther MM
    J Urol; 2001 Feb; 165(2):397-400. PubMed ID: 11176381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease.
    Goldfarb DA
    J Intern Med; 1998 Jun; 243(6):563-7. PubMed ID: 9681859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative surgical therapy of localized renal cell carcinoma in von Hippel-Lindau disease.
    Lund GO; Fallon B; Curtis MA; Williams RD
    Cancer; 1994 Nov; 74(9):2541-5. PubMed ID: 7923011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.
    Shinohara N; Nonomura K; Harabayashi T; Togashi M; Nagamori S; Koyanagi T
    J Urol; 1995 Dec; 154(6):2016-9. PubMed ID: 7500447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].
    Urbieta Anza A; Llarena Ibarguren R; Tomás Zabala Egurrola JA; Gutierrez Zurimendi G; Iturregui Del Pozo AM; Arruza Echevarria A
    Arch Esp Urol; 2018 Nov; 71(9):757-764. PubMed ID: 30403378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of the renal manifestations of von Hippel-Lindau disease: a review of a United Kingdom case series.
    Persad RA; Probert JL; Sharma SD; Haq A; Doyle PT
    Br J Urol; 1997 Sep; 80(3):392-6. PubMed ID: 9313655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study.
    Steinbach F; Novick AC; Zincke H; Miller DP; Williams RD; Lund G; Skinner DG; Esrig D; Richie JP; deKernion JB
    J Urol; 1995 Jun; 153(6):1812-6. PubMed ID: 7752324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical treatment of renal-cell carcinoma in von Hippel-Lindau disease].
    Uscanga-Yépez J; Rodríguez-Covarrubias F; Morales J; Granados J; Gabilondo-Navarro F
    Rev Invest Clin; 2013; 65(4):318-22. PubMed ID: 24304732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudotumors after renal parenchymal sparing surgery.
    Kshirsagar AV; Choyke PL; Linehan WM; Walther MM
    J Urol; 1998 Apr; 159(4):1148-51. PubMed ID: 9507819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and pathological manifestations of renal tumors in von Hippel-Lindau disease.
    Nelson JB; Oyasu R; Dalton DP
    J Urol; 1994 Dec; 152(6 Pt 2):2221-6. PubMed ID: 7966714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.
    Novick AC; Streem SB
    J Urol; 1992 Jun; 147(6):1488-90. PubMed ID: 1593671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.
    Poston CD; Jaffe GS; Lubensky IA; Solomon D; Zbar B; Linehan WM; Walther MM
    J Urol; 1995 Jan; 153(1):22-6. PubMed ID: 7966777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of von Hippel-Lindau disease with renal involvement].
    Chrétien Y; Chauveau D; Richard S; Droz D; Correas JM; Mejean A; Dufour B; Grünfeld JP
    Prog Urol; 1997 Dec; 7(6):939-47. PubMed ID: 9490138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
    Ploussard G; Droupy S; Ferlicot S; Ples R; Rocher L; Richard S; Benoit G
    Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.